Autolus Therapeutics releases 2025 annual report and financial statements
Autolus Therapeutics plc, a Nasdaq-listed biopharmaceutical company, published its annual report and consolidated financial statements for the year ended December 31, 2025. The filing provides comprehensive financial performance data and corporate governance information for the cell therapy developer.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day